HSCS
Heart Test Laboratories, Inc. (HSCS)
Last Price$2.95.0%
Market Cap$2,541.3M
$14.7K
-99.7% YoY
($7,624.6K)
+23.8% YoY
($1,148.5M)
Net Debt to FCF - 0.3x
($4,209.2M)
(28,634,171.0% margin)

HSCS Income Statement

HSCS Income Statement Overview

Annual
Quarterly
LTM
Apr'20
Apr'21
Apr'22
Apr'23
Apr'24
$18.6K 261.2% YoY
$12.5K 431.8% YoY
67.3% margin
Cost of revenue
$6,081.0 117.5% YoY
Operating expenses
$6,318.3K 3.3% YoY
Net income
$6,605.2K (98.7%) YoY
(35,511.9%) margin
Other: $6,605.2K
R&D
$2,878.6K 17.0% YoY
15,476.1% of revenue
SG&A
$3,439.7K (5.9%) YoY
18,493.2% of revenue

HSCS Income statement key metrics

Annual
Quarterly
LTM

Revenue

$18.6K +261.2% YoY

Operating Income

($6,305.8K) +3.2% YoY

Net Income

($6,605.2K) -98.7% YoY

HSCS Balance Sheet

HSCS Balance Sheet Overview

Annual
Quarterly
LTM
Apr'20
Apr'21
Apr'22
Apr'23
Apr'24
Assets
Liabilities
Total assets
$9,503.1K
Current assets ($7,353.9K, 77.4% of total)
$5,807.6K (61.1%)
Other current assets
$1,546.2K (16.3%)
Non-current assets ($2,149.2K, 22.6% of total)
$1,589.2K (16.7%)
Other non-current assets
$0.0 (0.0%)
Financial position
($4,771.3K)
$5,807.6K$1,036.3K
Cash & Short-term Investments
Total Debt

HSCS Balance Sheet Metrics

Annual
Quarterly
LTM

Assets

$9,503.1K +189.1% YoY

Liabilities

$2,185.8K -28.5% YoY

Shareholder's Equity

$7,317.3K +3,073.7% YoY

HSCS Cash Flow Statement

HSCS Cash Flow Statement Overview

Annual
Quarterly
LTM
Apr'20
Apr'21
Apr'22
Apr'23
Apr'24
Cash Beginning of PeriodOperating Cash FlowInvesting Cash FlowFinancing Cash FlowForex Changes on CashCash End of Period$1,660.5K($6,070.2K)($125.3K)$10.3M$0.0$5,807.6K

HSCS Cash Flow Statement key metrics

Annual
Quarterly
LTM

Operating Cash Flow (OCF)

($6,070.2K) +5.1% YoY

Capital Expenditure (CAPEX)

($125.3K) -98.3% YoY

Free Cash Flow (FCF)

($6,195.5K) -52.5% YoY

HSCS Financials

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Apr'20Apr'21Apr'22Apr'23Apr'24
% growth
0.1
0.0%
0.0
(60.1%)
0.0
(43.9%)
0.0
(64.2%)
0.0
261.2%
Cost of Goods Sold (COGS)0.00.00.00.00.0
% margin
0.0
27.6%
0.0
58.3%
0.0
45.1%
0.0
45.7%
0.0
67.3%
Operating Expenses3.82.64.76.16.3
Research & Development Expenses (R&D)2.01.73.02.52.9
Selling, General & Administrative Expenses (SG&A)1.80.91.73.73.4
(3.8)
(5,949.0%)
(2.6)
(10,030.2%)
(4.7)
(32,765.6%)
(6.1)
(118,698.3%)
(6.3)
(33,902.0%)
Interest Income0.00.10.40.20.0
Interest Expense0.00.10.40.20.4
Pre-tax Income(3.8)(2.5)(4.8)(6.4)(6.6)
% effective tax rate
0.0
(0.6%)
0.1
(5.3%)
(0.3)
5.2%
484.5
(7,624.8%)
0.0
0.0%
% margin
(3.8)
(5,973.4%)
(2.6)
(10,081.1%)
(4.6)
(31,851.8%)
(490.9)
(9,531,151.3%)
(6.6)
(35,511.9%)
EPS(115.69)(77.89)(137.94)(6,173.88)(18.74)
Diluted EPS(115.69)(77.89)(137.94)(6,173.88)(18.74)
% margin
(3.7)
(5,834.2%)
(2.3)
(8,928.7%)
(4.4)
(30,822.2%)
(6.1)
(118,139.8%)
(6.2)
(33,096.7%)